+36.1%
MRNA vs INSM
+392.8%
-356.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | INSM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.7% | +3.7% | +5.3% |
| 7D | -1.1% | +2.5% | -3.6% | -1.1% |
| 30D | +126.1% | -2.2% | +128.3% | +126.2% |
| 3M | +190.0% | +33.8% | +156.2% | +189.6% |
| 6M | +157.2% | -7.2% | +164.4% | +157.3% |
| YTD | +388.2% | -25.6% | +413.8% | +387.5% |
| 1Y | +467.0% | -11.2% | +478.3% | +468.2% |
| 3Y | +36.1% | +388.3% | -352.3% | +49.7% |
| All | +36.1% | +392.8% | -356.7% | +49.7% |
Cumulative growth
Daily Returns
Daily percentage return beside INSM.
Daily Out/Under-Performance
Portfolio return minus INSM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INSM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded INSM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling